These GLP-1 medications have quickly become some of the most talked-about weight loss drugs, with many people turning to them for rapid results
These drugs work by activating the GLP-1 receptor, which increases insulin secretion and improves the livers use of glucose
The compound is provided as a lyophilized peptide preparation intended for controlled research environments
However, clinical trials have not demonstrated that semaglutide directly harms thyroid tissue or reduces thyroid hormone output in most patients
8.2 Lactation Risk Summary There is no information regarding the presence of BYETTA, in human milk, the effects of BYETTA on the breastfed infant, or the effects of BYETTA on milk production
It was the first pill version of a GLP-1 medication when it launched in the US in early January and has so far proved very popular